{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:19:00Z","timestamp":1791847140961,"version":"4.3.4"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014832","name":"American Headache Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014832","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11916-025-01463-3","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:46:53Z","timestamp":1770187613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Management of Myogenous Temporomandibular Disorders with Botulinum Toxin: A Narrative Review and Management Recommendations"],"prefix":"10.1007","volume":"30","author":[{"given":"Paul G.","family":"Mathew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Romero-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrittej S.","family":"Virk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador L.","family":"Manrriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Teruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie E.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Tanenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rich","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"1463_CR1","volume-title":"Orofacial Pain Guidelines for Assessment, Diagnosis, and Managament","author":"G Klasser","year":"2023","unstructured":"Klasser G, Romero Reyes M. Orofacial Pain Guidelines for Assessment, Diagnosis, and Managament. 7th edition. Quintessence Publishing; 2023.","edition":"7th edition"},{"key":"1463_CR2","doi-asserted-by":"crossref","unstructured":"Dworkin SF. Temporomandibular disorder (TMD) pain-related disability found related to depression, nonspecific physical symptoms, and pain duration at 3 international sites. J Evid Based Dent Pract 2011;11:143\u2013144.","DOI":"10.1016\/j.jebdp.2011.06.002"},{"key":"1463_CR3","doi-asserted-by":"crossref","unstructured":"Dworkin SF, Huggins KH, LeResche L, et al. Epidemiology of signs and symptoms in temporomandibular disorders: clinical signs in cases and controls. J Am Dent Assoc 1990;120:273\u2013281.","DOI":"10.14219\/jada.archive.1990.0043"},{"key":"1463_CR4","unstructured":"NIDCR. Prevalence of TMJD and its Signs and Symptoms \u2212\u20092018. <https:\/\/www.nidcr.nih.gov\/research\/data-statistics\/facial-pain\/prevalence>."},{"key":"1463_CR5","unstructured":"Johansson A, Unell L, Carlsson GE, Soderfeldt B, Halling A. Gender difference in symptoms related to temporomandibular disorders in a population of 50-year-old subjects. J Orofac Pain 2003;17:29\u201335."},{"key":"1463_CR6","doi-asserted-by":"crossref","unstructured":"Slade GD, Rosen JD, Ohrbach R, et al. Anatomical selectivity in overlap of chronic facial and bodily pain. Pain Rep. 2019;4:e729.","DOI":"10.1097\/PR9.0000000000000729"},{"key":"1463_CR7","unstructured":"Fricton J, R D,. Epidemiology of Temporomandibular Disorders. In: Fricton J, R D, Eds, ed. Advances in Pain Research and Therapy: Orofacial Pain and Temporomandibular Disorders. Yew York: Raven Press, 1995: 1\u201314."},{"key":"1463_CR8","first-page":"224","volume":"14","author":"M Kamisaka","year":"2000","unstructured":"Kamisaka M, Yatani H, Kuboki T, Matsuka Y, Minakuchi H. Four-year longitudinal course of TMD symptoms in an adult population and the estimation of risk factors in relation to symptoms. J Orofac Pain. 2000;14:224\u201332.","journal-title":"J Orofac Pain"},{"key":"1463_CR9","doi-asserted-by":"crossref","unstructured":"Manfredini D, Favero L, Gregorini G, Cocilovo F, Guarda-Nardini L. Natural course of temporomandibular disorders with low pain-related impairment: a 2-to-3-year follow-up study. J Oral Rehabil. 2013;40:436\u2013442.","DOI":"10.1111\/joor.12047"},{"key":"1463_CR10","unstructured":"National Academies of Sciences E, Medicine, Health, Medicine D, Board on Health Care S, Board on Health Sciences P, et al. The National Academies Collection: Reports funded by National Institutes of Health. In: Yost O, Liverman CT, English R, Mackey S, Bond EC, editors. Temporomandibular Disorders: Priorities for Research and Care. Washington (DC): National Academies Press (US)"},{"key":"1463_CR11","unstructured":"Klasser GD, Abt E, Weyant RJ, Greene CS. Temporomandibular disorders: current status of research, education, policies, and its impact on clinicians in the United States of America. Quintessence international (Berlin, Germany : 1985). 2022 Dec 22;0(0):1\u201320."},{"issue":"10","key":"1463_CR12","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1177\/0022034516653743","volume":"95","author":"GD Slade","year":"2016","unstructured":"Slade GD, Ohrbach R, Greenspan JD, Fillingim RB, Bair E, Sanders AE, et al. Painful temporomandibular disorder: decade of discovery from OPPERA studies. J Dent Res. 2016;95(10):1084\u201392.","journal-title":"J Dent Res"},{"key":"1463_CR13","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1177\/0022034515595043","volume":"94","author":"GD Slade","year":"2015","unstructured":"Slade GD, Sanders AE, Ohrbach R, et al. COMT diplotype amplifies effect of stress on risk of temporomandibular pain. J Dent Res. 2015;94:1187\u201395.","journal-title":"J Dent Res."},{"key":"1463_CR14","doi-asserted-by":"crossref","unstructured":"Smith SB, Maixner DW, Greenspan JD, et al. Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study. J Pain. 2011;12:T92-101.","DOI":"10.1016\/j.jpain.2011.08.005"},{"key":"1463_CR15","doi-asserted-by":"crossref","unstructured":"Sharma S, Wactawski-Wende J, LaMonte MJ, et al. Incident injury is strongly associated with subsequent incident temporomandibular disorder: results from the OPPERA study. Pain. 2019;160:1551\u20131561.","DOI":"10.1097\/j.pain.0000000000001554"},{"key":"1463_CR16","doi-asserted-by":"crossref","unstructured":"Fillingim RB, Ohrbach R, Greenspan JD, et al. Psychological factors associated with development of TMD: the OPPERA prospective cohort study. J Pain. 2013;14:T75-90.","DOI":"10.1016\/j.jpain.2013.06.009"},{"key":"1463_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.expneurol.2015.05.005","volume":"271","author":"M Romero-Reyes","year":"2015","unstructured":"Romero-Reyes M, Pardi V, Akerman S. A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: role of CGRP in orofacial pain. Exp Neurol. 2015;271:95\u2013103.","journal-title":"Exp Neurol"},{"key":"1463_CR18","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1111\/bph.15263","volume":"177","author":"S Akerman","year":"2020","unstructured":"Akerman S, Romero-Reyes M. Preclinical studies investigating the neural mechanisms involved in the co-morbidity of migraine and temporomandibular disorders: the role of CGRP. Br J Pharmacol. 2020;177:5555\u201368.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1463_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/joor.12132","volume":"41","author":"CC Peck","year":"2014","unstructured":"Peck CC, Goulet JP, Lobbezoo F, Schiffman EL, Alstergren P, Anderson GC, et al. Expanding the taxonomy of the diagnostic criteria for temporomandibular disorders. J Oral Rehabil. 2014;41(1):2\u201323.","journal-title":"J Oral Rehabil"},{"key":"1463_CR20","doi-asserted-by":"crossref","unstructured":"International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia. 2020;40(2):129\u2013221.","DOI":"10.1177\/0333102419893823"},{"key":"1463_CR21","doi-asserted-by":"crossref","unstructured":"Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC\/TMD) for Clinical and Research Applications: recommendations of the International RDC\/TMD Consortium Network* and Orofacial Pain Special Interest Groupdagger. J Oral Facial Pain Headache 2014;28:6\u201327.","DOI":"10.11607\/jop.1151"},{"issue":"18","key":"1463_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18189842","volume":"18","author":"J Ku\u0107","year":"2021","unstructured":"Ku\u0107 J, Szarejko KD, Go\u0142\u0119biewska M. The prevalence and overlaps of temporomandibular disorders in patients with myofascial pain with referral-a pilot study. Int J Environ Res Public Health. 2021;18(18):9842.","journal-title":"Int J Environ Res Public Health"},{"key":"1463_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1154","volume":"350","author":"J Durham","year":"2015","unstructured":"Durham J, Newton-John TR, Zakrzewska JM. Temporomandibular disorders. BMJ. 2015;350:h1154.","journal-title":"BMJ"},{"key":"1463_CR24","doi-asserted-by":"crossref","unstructured":"Nixdorf DR, Law AS, John MT, Sobieh RM, Kohli R, et al. Differential diagnoses for persistent pain following root canal treatment: A study in the national dental PBRN. J Endod 2015;41(4):457\u2013463.","DOI":"10.1016\/j.joen.2014.12.012"},{"key":"1463_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.molmed.2018.12.007","volume":"25","author":"RP Donahue","year":"2019","unstructured":"Donahue RP, Hu JC, Athanasiou KA. Remaining hurdles for tissue-engineering the temporomandibular joint disc. Trends Mol Med. 2019;25:241\u201356.","journal-title":"Trends Mol Med"},{"key":"1463_CR26","first-page":"1","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1\u2013211.","journal-title":"Cephalalgia"},{"key":"1463_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1526-4610.2009.01511.x","volume":"50","author":"DA Goncalves","year":"2010","unstructured":"Goncalves DA, Bigal ME, Jales LC, Camparis CM, Speciali JG. Headache and symptoms of temporomandibular disorder: an epidemiological study. Headache. 2010;50:231\u201341.","journal-title":"Headache"},{"issue":"2","key":"1463_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cden.2022.10.005","volume":"67","author":"DC Thomas","year":"2023","unstructured":"Thomas DC, Khan J, Manfredini D, Ailani J. Temporomandibular joint disorder comorbidities. Dent Clin North Am. 2023;67(2):379\u201392.","journal-title":"Dent Clin North Am"},{"issue":"10","key":"1463_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11910-023-01291-1","volume":"23","author":"M Romero-Reyes","year":"2023","unstructured":"Romero-Reyes M, Klasser G, Akerman S. An update on temporomandibular disorders (TMDs) and headache. Curr Neurol Neurosci Rep. 2023;23(10):561\u201370.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1463_CR30","first-page":"287","volume":"24","author":"AL Franco","year":"2010","unstructured":"Franco AL, Goncalves DA, Castanharo SM, Speciali JG, Bigal ME, Camparis CM. Migraine is the most prevalent primary headache in individuals with temporomandibular disorders. J Orofac Pain. 2010;24:287\u201392.","journal-title":"J Orofac Pain"},{"issue":"1","key":"1463_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.joms.2021.06.010","volume":"80","author":"CS Greene","year":"2022","unstructured":"Greene CS, Kusiak JW, Cowley T, Cowley AW Jr. Recently released report by major scientific academy proposes significant changes in understanding and managing temporomandibular disorders. J Oral Maxillofac Surg. 2022;80(1):8\u20139.","journal-title":"J Oral Maxillofac Surg"},{"key":"1463_CR32","unstructured":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Board on Health Sciences Policy; Committee on Temporomandibular Disorders (TMDs): From Research Discoveries to Clinical Treatment. Temporomandibular Disorders: Priorities for Research and Care. In: Yost O, Liverman CT, English R, Mackey S, Bond EC, editors. Washington (DC): National Academies Press (US); 2020."},{"key":"1463_CR33","doi-asserted-by":"publisher","first-page":"364","DOI":"10.14219\/jada.archive.1984.0002","volume":"108","author":"GT Clark","year":"1984","unstructured":"Clark GT. A critical evaluation of orthopedic interocclusal appliance therapy: effectiveness for specific symptoms. J Am Dent Assoc. 1984;108:364\u20138.","journal-title":"J Am Dent Assoc"},{"key":"1463_CR34","first-page":"237","volume":"24","author":"J Fricton","year":"2010","unstructured":"Fricton J, Look JO, Wright E, et al. Systematic review and meta-analysis of randomized controlled trials evaluating intraoral orthopedic appliances for temporomandibular disorders. J Orofac Pain. 2010;24:237\u201354.","journal-title":"J Orofac Pain"},{"key":"1463_CR35","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1365-2842.2010.02089.x","volume":"37","author":"T List","year":"2010","unstructured":"List T, Axelsson S. Management of TMD: evidence from systematic reviews and meta-analyses. J Oral Rehabil. 2010;37:430\u201351.","journal-title":"J Oral Rehabil"},{"issue":"14","key":"1463_CR36","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s40265-023-01927-z","volume":"83","author":"M Romero-Reyes","year":"2023","unstructured":"Romero-Reyes M, Arman S, Teruel A, Kumar S, Hawkins J, Akerman S. Pharmacological management of orofacial pain. Drugs. 2023;83(14):1269\u201392.","journal-title":"Drugs"},{"issue":"10","key":"1463_CR37","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11910-023-01291-1","volume":"23","author":"M Romero-Reyes","year":"2023","unstructured":"Romero-Reyes M, Klasser G, Akerman S. An update on temporomandibular disorders (TMDs) and headache. Curr Neurol Neurosci Rep. 2023;23(10):561\u201370. https:\/\/doi.org\/10.1007\/s11910-023-01291-1.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1463_CR38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cden.2013.04.006","volume":"57","author":"F Liu","year":"2013","unstructured":"Liu F, Steinkeler A. Epidemiology, diagnosis, and treatment of temporomandibular disorders. Dent Clin North Am. 2013;57:465\u201379.","journal-title":"Dent Clin North Am"},{"key":"1463_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.coms.2007.12.004","volume":"20","author":"R de Leeuw","year":"2008","unstructured":"de Leeuw R. Internal derangements of the temporomandibular joint. Oral Maxillofac Surg Clin North Am. 2008;20:159\u201368.","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"1463_CR40","doi-asserted-by":"crossref","unstructured":"Dolwick MF. Temporomandibular joint surgery for internal derangement. Dent Clin North Am 2007;51:195\u2013208, vii-viii.","DOI":"10.1016\/j.cden.2006.10.003"},{"key":"1463_CR41","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1526-4637.2010.00801.x","volume":"11","author":"SH Yoon","year":"2010","unstructured":"Yoon SH, Merrill RL, Choi JH, Kim ST. Use of botulinum toxin type A injection for neuropathic pain after trigeminal nerve injury. Pain Med. 2010;11:630\u20132.","journal-title":"Pain Med"},{"key":"1463_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/NDT.S17923","volume":"8","author":"CE Robertson","year":"2012","unstructured":"Robertson CE, Garza I. Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine. Neuropsychiatr Dis Treat. 2012;8:35\u201348.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1463_CR43","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/head.13849","volume":"60","author":"R Burstein","year":"2020","unstructured":"Burstein R, Blumenfeld AM, Silberstein SD, Manack Adams A, Brin MF. Mechanism of action of onabotulinumtoxinA in chronic migraine: a narrative review. Headache. 2020;60:1259\u201372.","journal-title":"Headache"},{"key":"1463_CR44","doi-asserted-by":"crossref","unstructured":"Matak I, Bolcskei K, Bach-Rojecky L, Helyes Z. Mechanisms of botulinum toxin type A action on pain. Toxins (Basel) 2019;11.","DOI":"10.3390\/toxins11080459"},{"key":"1463_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.toxicon.2020.02.017","volume":"178","author":"D Martinelli","year":"2020","unstructured":"Martinelli D, Arceri S, Tronconi L, Tassorelli C. Chronic migraine and botulinum toxin type A: where do paths cross? Toxicon. 2020;178:69\u201376.","journal-title":"Toxicon"},{"key":"1463_CR46","doi-asserted-by":"crossref","unstructured":"Drinovac F, Bach-Rojecky, Lackovic. Role of central versus peripheral opioid system in antinociceptive and anti-inflammatory effect of botulinum toxin type A in trigeminal region. Eur J Pain. 2018;22:583\u2013591.","DOI":"10.1002\/ejp.1146"},{"key":"1463_CR47","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1054\/bjom.1999.0238","volume":"38","author":"B Freund","year":"2000","unstructured":"Freund B, Schwartz M, Symington JM. Botulinum toxin: new treatment for temporomandibular disorders. Br J Oral Maxillofac Surg. 2000;38:466\u201371.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1463_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0304-3959(94)90048-5","volume":"59","author":"WP Cheshire","year":"1994","unstructured":"Cheshire WP, Abashian SW, Mann DJ. Botulinum toxin in the treatment of myofascial pain syndrome. Pain. 1994;59:65\u20139.","journal-title":"Pain"},{"key":"1463_CR49","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.joms.2008.03.008","volume":"66","author":"C Kurtoglu","year":"2008","unstructured":"Kurtoglu C, Gur OH, Kurkcu M, Sertdemir Y, Guler-Uysal F, Uysal H. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. J Oral Maxillofac Surg. 2008;66:1644\u201351.","journal-title":"J Oral Maxillofac Surg"},{"key":"1463_CR50","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.pain.2011.03.036","volume":"152","author":"M Ernberg","year":"2011","unstructured":"Ernberg M, Hedenberg-Magnusson B, List T, Svensson P. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Pain. 2011;152:1988\u201396.","journal-title":"Pain"},{"key":"1463_CR51","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41415-019-0257-z","volume":"226","author":"J Patel","year":"2019","unstructured":"Patel J, Cardoso JA, Mehta S. A systematic review of botulinum toxin in the management of patients with temporomandibular disorders and bruxism. Br Dent J. 2019;226:667\u201372.","journal-title":"Br Dent J"},{"issue":"1","key":"1463_CR52","doi-asserted-by":"publisher","first-page":"6","DOI":"10.11607\/ofph.3023","volume":"36","author":"R Delcanho","year":"2022","unstructured":"Delcanho R, Val M, Nardini LG, Manfredini D. Botulinum toxin for treatment temporomandibular disorders: what is the evidence? J Oral Facial Pain Headache. 2022;36(1):6\u201320.","journal-title":"J Oral Facial Pain Headache"},{"key":"1463_CR53","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.bjoms.2016.04.008","volume":"54","author":"LD Zhang","year":"2016","unstructured":"Zhang LD, Liu Q, Zou DR, Yu LF. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX - A)for treatment of temporomandibular disorder. Br J Oral Maxillofac Surg. 2016;54:736\u201340.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1463_CR54","doi-asserted-by":"publisher","first-page":"e559","DOI":"10.1212\/WNL.0000000000004951","volume":"90","author":"WG Ondo","year":"2018","unstructured":"Ondo WG, Simmons JH, Shahid MH, Hashem V, Hunter C, Jankovic J. Onabotulinum toxin-A injections for sleep bruxism: a double-blind, placebo-controlled study. Neurology. 2018;90:e559\u201364.","journal-title":"Neurology"},{"key":"1463_CR55","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jphotobiol.2016.03.038","volume":"159","author":"BM De Carli","year":"2016","unstructured":"De Carli BM, Magro AK, Souza-Silva BN, Matos Fde S, De Carli JP, Paranhos LR, et al. The effect of laser and botulinum toxin in the treatment of myofascial pain and mouth opening: a randomized clinical trial. J Photochem Photobiol B. 2016;159:120\u20133.","journal-title":"J Photochem Photobiol B"},{"issue":"2","key":"1463_CR56","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1179\/crn.2008.017","volume":"26","author":"Luca Guarda-Nardini","year":"2008","unstructured":"Guarda-Nardini Luca, Manfredini Daniele, Salamone Milena, Salmaso Luigi, Tonello Stefano, Ferronato Giuseppe. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. CRANIO\u00ae. 2008;26(2):126\u201335. https:\/\/doi.org\/10.1179\/crn.2008.017.","journal-title":"CRANIO\u00ae"},{"key":"1463_CR57","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ijom.2015.04.003","volume":"44","author":"YW Chen","year":"2015","unstructured":"Chen YW, Chiu YW, Chen CY, Chuang SK. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials. Int J Oral Maxillofac Surg. 2015;44:1018\u201326.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"1463_CR58","doi-asserted-by":"crossref","unstructured":"Sitnikova V, K\u00e4mppi A, K\u00e4mppi L, Alvesalo E, Burakova M, Kemppainen P, Teronen O. Clinical benefit of botulinum toxin for treatment of persistent TMD-related myofascial pain: A randomized, placebo-controlled, cross-over trial. Pain Pract. 2024.","DOI":"10.1111\/papr.13396"},{"issue":"7","key":"1463_CR59","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s40265-024-02048-x","volume":"84","author":"G la De Torre Canales","year":"2024","unstructured":"la De Torre Canales G, C\u00e2mara-Souza MB, Ernberg M, Al-Moraissi EA, Grigoriadis A, Poluha RL, et al. Botulinum toxin-A for the treatment of myogenous temporomandibular disorders: an umbrella review of systematic reviews. Drugs. 2024;84(7):779\u2013809.","journal-title":"Drugs"},{"key":"1463_CR60","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.3390\/toxins7082791","volume":"7","author":"N Mor","year":"2015","unstructured":"Mor N, Tang C, Blitzer A. Temporomandibular myofacial pain treated with botulinum toxin injection. Toxins (Basel). 2015;7:2791\u2013800.","journal-title":"Toxins (Basel)"},{"key":"1463_CR61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.bjoms.2012.07.002","volume":"51","author":"AJ Sidebottom","year":"2013","unstructured":"Sidebottom AJ, Patel AA, Amin J. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study. Br J Oral Maxillofac Surg. 2013;51:199\u2013205.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1463_CR62","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1179\/crn.2008.017","volume":"26","author":"L Guarda-Nardini","year":"2008","unstructured":"Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio. 2008;26:126\u201335.","journal-title":"Cranio"},{"key":"1463_CR63","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1177\/0022034519875053","volume":"98","author":"VRM Munoz Lora","year":"2019","unstructured":"Munoz Lora VRM, Del Bel Cury AA, Jabbari B, Lackovic Z. Botulinum toxin type A in dental medicine. J Dent Res. 2019;98:1450\u20137.","journal-title":"J Dent Res"},{"key":"1463_CR64","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/joor.12180","volume":"41","author":"KG Raphael","year":"2014","unstructured":"Raphael KG, Tadinada A, Bradshaw JM, et al. Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study. J Oral Rehabil. 2014;41:555\u201363.","journal-title":"J Oral Rehabil"},{"issue":"1","key":"1463_CR65","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00223-017-0385-x","volume":"103","author":"EH Dutra","year":"2018","unstructured":"Dutra EH, O\u2019Brien MH, Logan C, Tadinada A, Nanda R, Yadav S. Loading of the condylar cartilage can rescue the effects of Botox on TMJ. Calcif Tissue Int. 2018;103(1):71\u20139.","journal-title":"Calcif Tissue Int"},{"key":"1463_CR66","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/joor.13326","volume":"49","author":"M Owen","year":"2022","unstructured":"Owen M, Gray B, Hack N, Perez L, Allard RJ, Hawkins JM. Impact of botulinum toxin injection into the masticatory muscles on mandibular bone: a systematic review. J Oral Rehabil. 2022;49:644\u201353.","journal-title":"J Oral Rehabil"},{"key":"1463_CR67","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/joor.13590","volume":"51","author":"MS Moussa","year":"2024","unstructured":"Moussa MS, Bachour D, Komarova SV. Adverse effect of botulinum toxin-A injections on mandibular bone: a systematic review and meta-analysis. J Oral Rehabil. 2024;51:404\u201315.","journal-title":"J Oral Rehabil"},{"key":"1463_CR68","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/joor.12663","volume":"45","author":"F Lobbezoo","year":"2018","unstructured":"Lobbezoo F, Ahlberg J, Raphael KG, et al. International consensus on the assessment of bruxism: Report of a work in progress. J Oral Rehabil. 2018;45:837\u201344.","journal-title":"J Oral Rehabil."},{"key":"1463_CR69","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/ors.12454","volume":"13","author":"D Manfredini","year":"2020","unstructured":"Manfredini D, Colonna A, Bracci A, Lobbezoo F. Bruxism: a summary of current knowledge on aetiology, assessment and management. Oral Surg. 2020;13:358\u201370.","journal-title":"Oral Surg"},{"key":"1463_CR70","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/jnnp.53.6.530","volume":"53","author":"M Van Zandijcke","year":"1990","unstructured":"Van Zandijcke M, Marchau MM. Treatment of bruxism with botulinum toxin injections. J Neurol Neurosurg Psychiatry. 1990;53:530.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1463_CR71","doi-asserted-by":"crossref","unstructured":"De La Torre Canales CS, do Amaral, Garcia, Manfredini. Is there enough evidence to use botulinum toin injections for bruxism management? A systematic literature review. Clin Oral Investig 2017;21(3):727\u2013734","DOI":"10.1007\/s00784-017-2092-4"},{"key":"1463_CR72","doi-asserted-by":"publisher","first-page":"291","DOI":"10.5664\/jcsm.3532","volume":"10","author":"YJ Shim","year":"2014","unstructured":"Shim YJ, Lee MK, Kato T, Park HU, Heo K, Kim ST. Effects of botulinum toxin on jaw motor events during sleep in sleep bruxism patients: a polysomnographic evaluation. J Clin Sleep Med. 2014;10:291\u20138.","journal-title":"J Clin Sleep Med"},{"key":"1463_CR73","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/0003489417693013","volume":"126","author":"AA Patel","year":"2017","unstructured":"Patel AA, Lerner MZ, Blitzer A. IncobotulinumtoxinA injection for temporomandibular joint disorder. Ann Otol Rhinol Laryngol. 2017;126:328\u201333.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"1463_CR74","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","volume":"50","author":"DW Dodick","year":"2010","unstructured":"Dodick DW, Turkel CC, DeGryse RE, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010;50:921\u201336.","journal-title":"Headache"},{"issue":"3","key":"1463_CR75","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0304-3959(02)00240-3","volume":"99","author":"DR Nixdorf","year":"2002","unstructured":"Nixdorf DR, Heo G, Major PW. Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain. Pain. 2002;99(3):465\u201373.","journal-title":"Pain"},{"issue":"1","key":"1463_CR76","doi-asserted-by":"publisher","first-page":"6","DOI":"10.11607\/ofph.3023","volume":"36","author":"R Delcanho","year":"2022","unstructured":"Delcanho R, Val M, Nardini LG, Manfredini D. Botulinum toxin for treatment temporomandibular disorders: what is the evidence? J Oral Facial Pain Headache. 2022;36(1):6\u201320.","journal-title":"J Oral Facial Pain Headache"},{"key":"1463_CR77","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0278-2391(03)00153-8","volume":"61","author":"JJ von Lindern","year":"2003","unstructured":"von Lindern JJ, Niederhagen B, Berge S, Appel T. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg. 2003;61:774\u20138.","journal-title":"J Oral Maxillofac Surg"},{"key":"1463_CR78","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.3390\/toxins7082791","volume":"7","author":"N Mor","year":"2015","unstructured":"Mor N, Tang C, Blitzer A. Toxins temporomandibular myofacial pain treated with botulinum toxin injection. Toxins. 2015;7:2791\u2013800.","journal-title":"Toxins."},{"key":"1463_CR79","doi-asserted-by":"crossref","unstructured":"Martenot A, Devoti JF, Pons M, Meyer C, Brumpt E, Louvrier A, Bertin E.\u00a0Persistent myogenic temporomandibular disorders: Are navigation-guided botulinum toxin-A injections into the lateral pterygoid muscles effective? J Stomatol Oral Maxillofac Surg. 2024;125(5)","DOI":"10.1016\/j.jormas.2023.101715"},{"key":"1463_CR80","doi-asserted-by":"crossref","unstructured":"Nixdorf. Randomized controlled trial of botulinum toxin a for chronic myogenous orofacial pain. Pain.\u00a02002;99:465\u2013473.","DOI":"10.1016\/S0304-3959(02)00240-3"},{"key":"1463_CR81","doi-asserted-by":"crossref","unstructured":"Cem Kurtoglu DDS, PhD, Osman Hayri Gur DDS, PhD, Mehmet Kurkcu DDS, MSc, PhD, Yasar Sertdemir PhD, Fusun Guler-Uysal MD and Hakan Uysal DDS, PhD. Effect of Botulinum Toxin-A in Myofascial Pain Patients With or Without Functional Disc Displacement. Journal of Oral and Maxillofacial Surgery, 2008-08-01, Volume 66, Issue 8, Pages 1644\u20131651, Copyright \u00a9 2008 American Association of Oral and Maxillofacial Surgeons.","DOI":"10.1016\/j.joms.2008.03.008"},{"key":"1463_CR82","doi-asserted-by":"crossref","unstructured":"Altaweel, AA et. Al. Extraoral versus intraoral botulinum toxin type a injection for management of temporomandibular joint disc displacement with reduction. J Craniofac Surg.\u00a02019;30(7):2149\u20132153","DOI":"10.1097\/SCS.0000000000005658"},{"key":"1463_CR83","unstructured":"Clark: Phys Med Rehab Clin N AM, 2003: 14 727\u2009\u2212\u200948"},{"key":"1463_CR84","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0901-5027(97)80014-8","volume":"26","author":"B Daelen","year":"1997","unstructured":"Daelen B, Thorwirth V, Koch A. Treatment of recurrent dislocation of the temporomandibular joint with type a botulinum toxin. Int J Oral Maxillofac Surg. 1997;26:458\u201360.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"1463_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.msksp.2020.102197","volume":"49","author":"JA Mesa-Jim\u00e9nez","year":"2020","unstructured":"Mesa-Jim\u00e9nez JA, Fern\u00e1ndez-De-Las-Pe\u00f1as C, Koppenhaver SL, S\u00e1nchez-Guti\u00e9rrez J, Arias-Bur\u00eda JL. Cadaveric and in vivo validation of needle placement in the medial pterygoid muscle. Musculoskelet Sci Pract. 2020;49:102197. https:\/\/doi.org\/10.1016\/j.msksp.2020.102197.","journal-title":"Musculoskelet Sci Pract"},{"issue":"2","key":"1463_CR86","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/mdc3.12460","volume":"4","author":"K Yoshida","year":"2016","unstructured":"Yoshida K. How do I inject botulinum toxin into the lateral and medial pterygoid muscles? Mov Disord Clin Pract. 2016;4(2):285.","journal-title":"Mov Disord Clin Pract."},{"issue":"1","key":"1463_CR87","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12903-022-02220-3","volume":"22","author":"F Rezazadeh","year":"2022","unstructured":"Rezazadeh F, Esnaashari N, Azad A, Emad S. The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study. BMC Oral Health. 2022;22(1):217.","journal-title":"BMC Oral Health."},{"key":"1463_CR88","doi-asserted-by":"crossref","unstructured":"Taema M, Nabi NA, Ibrahim S, Kamal HA, Emara A. Assessment of anterior positioning splint in conjunction with lateral pterygoid BTX injection to treat TMJ disc displacement with reduction - a preliminary report. Maxillofac Plast Reconstr Surg. 2021;43(1):33.","DOI":"10.1186\/s40902-021-00317-3"},{"issue":"5","key":"1463_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jormas.2023.101715","volume":"125","author":"A Martenot","year":"2024","unstructured":"Martenot A, Devoti JF, Pons M, Meyer C, Brumpt E, Louvrier A, et al. Persistent myogenic temporomandibular disorders: are navigation-guided botulinum toxin-A injections into the lateral pterygoid muscles effective? J Stomatol Oral Maxillofac Surg. 2024;125(5):101715.","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"1463_CR90","doi-asserted-by":"crossref","unstructured":"Sanjuan-Sanjuan A, Alamillos-Granadosb FJ, Dean-Ferrerc A, Estero-Serrano de la Cruza M, Mendez-Garc\u00edad M, Murga-Oportoe L. Electromyography assited application of botulinum toxin in pterygoid musculature for the treatment of masticatory myofascial pain. Revista Espa\u00f1ola de Cirug\u00eda Oral y Maxilofacial. 2019;41. 10.20986\/recom.2019.1017\/2018.","DOI":"10.20986\/recom.2019.1017\/2018"},{"issue":"4","key":"1463_CR91","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/ors.12473","volume":"13","author":"FP Kapos","year":"2020","unstructured":"Kapos FP, Exposto FG, Oyarzo JF, Durham J. Temporomandibular disorders: a review of current concepts in aetiology, diagnosis and management. Oral Surg. 2020;13(4):321\u201334.","journal-title":"Oral Surg"},{"issue":"3","key":"1463_CR92","doi-asserted-by":"publisher","first-page":"405","DOI":"10.17219\/dmp\/200127","volume":"62","author":"M Val","year":"2025","unstructured":"Val M, Manfredini D, Guarda Nardini L. Is botulinum toxin the future of orofacial pain management? Evidence and perspectives. Dent Med Probl. 2025;62(3):405\u20137.","journal-title":"Dent Med Probl"},{"key":"1463_CR93","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/joor.12180","volume":"41","author":"KG Raphael","year":"2014","unstructured":"Raphael KG, Tadinada A, Bradshaw JM, et al. Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study. J Oral Rehabil. 2014;41:555\u201363.","journal-title":"J Oral Rehabil."},{"key":"1463_CR94","doi-asserted-by":"crossref","unstructured":"Nassif AD, Boggio RF, Espicalsky S, Faria GEL. High Precision Use of Botulinum Toxin Type A (BONT-A) in Aesthetics Based on Muscle Atrophy, Is Muscular Architecture Reprogramming a Possibility? A Systematic Review of Literature on Muscle Atrophy after BoNT-A Injections. Toxins (Basel). 2022;14(2):81.","DOI":"10.3390\/toxins14020081"},{"issue":"4","key":"1463_CR95","first-page":"328","volume":"54","author":"GD Klasser","year":"2023","unstructured":"Klasser GD, Abt E, Weyant RJ, Greene CS. Temporomandibular disorders: current status of research, education, policies, and its impact on clinicians in the United States of America. Quintessence Int. 2023;54(4):328\u201334.","journal-title":"Quintessence Int"},{"key":"1463_CR96","doi-asserted-by":"crossref","unstructured":"Serrera-Figallo MA, Ruiz-de-Leon-Hernandez G, Torres-Lagares D, et al. Use of botulinum toxin in orofacial clinical practice. Toxins (Basel) 2020;12.","DOI":"10.3390\/toxins12020112"},{"issue":"1","key":"1463_CR97","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1038\/s41598-024-54906-z","volume":"14","author":"Canales G De la Torre","year":"2024","unstructured":"De la Torre Canales G, Poluha RL, Bonjardim LR, Ernberg M, Conti PCR. Botulinum toxin-A effects on pain, somatosensory and psychosocial features of patients with refractory masticatory myofascial pain: a randomized double-blind clinical trial. Sci Rep. 2024;14(1):4201.","journal-title":"Sci Rep."}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-025-01463-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-025-01463-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-025-01463-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:03:24Z","timestamp":1770192204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-025-01463-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1463"],"URL":"https:\/\/doi.org\/10.1007\/s11916-025-01463-3","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"Dr. Mathew has served as a consultant for Abbvie.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}